Delivery Order SPE2D021D0003-SPE2D024F0104
Award Date 2/29/24
Potential Completion Date 4/3/25
Potential Value $122K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Hoffman Estates, IL 60195, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Sagent Pharmaceuticals, Inc., a specialty pharmaceutical manufacturer. The $117,701.97 firm fixed price contract is for the supply of various injectable pharmaceutical products, including antibiotics and anesthesia medications, to support military healthcare programs. The contract has an ultimate completion date of April 3, 2024. Sagent Pharmaceuticals is an experienced federal contractor,...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Sagent Pharmaceuticals, Inc. The contract has a ceiling value of $58,926.51 and is a delivery order with a firm fixed price pricing type. The contract does not have a set-aside designation, indicating Sagent Pharmaceuticals competed on an unrestricted basis. The contract is for the delivery of various injectable pharmaceutical products, such as antibiotics, critical care medications, and...
- This is a firm fixed price delivery order awarded by the Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh to Sagent Pharmaceuticals, Inc., a specialty pharmaceutical manufacturer. The $13,146,933.60 indefinite-delivery, indefinite-quantity (IDIQ) contract is for the delivery of injectable pharmaceutical products, including antibiotics and anesthesia drugs, to support military health care programs. The contract has a period of performance through...
- This is a $3,083,212.80 firm fixed-price delivery order contract awarded by the Centers for Disease Control and Prevention (CDC) to Sagent Pharmaceuticals, Inc., a specialty pharmaceutical manufacturer. The contract, which does not have a set-aside designation, is for the supply of injectable pharmaceutical products such as antibiotics, critical care medications, and anesthesia drugs to support military healthcare programs and other federal medical needs. Sagent Pharmaceuticals is a prime...
- This is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Medical Supply Chain. The $47,051.52 contract has a completion date of May 6, 2025 and is not set aside. It provides for the delivery of a variety of pharmaceutical and medical products, including medications across therapeutic areas such as diabetes, neurology, pain management, and antibiotics, as well as specialized medical supplies. This...
- This is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen Drug Corp and the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued at $999,999,999, provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The specific delivery order has a ceiling value of $3,560.63 and a completion date of May 5, 2023. It is a firm fixed price contract for the procurement of...
- This is a $903,274.12 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Medical Supply Chain. The contract is for the delivery of various pharmaceutical products and medical supplies, including medications across multiple therapeutic areas such as diabetes, neurology, pain management, and antibiotics. The contract is not designated as a set-aside and is part of a larger $999,999,999.00...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a major defense agency, to Amerisourcebergen Drug Corp, a large pharmaceutical distributor. The contract, valued at $2,467.19, is for the delivery of a variety of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits. This contract is a task order under a larger Indefinite Delivery Contract (IDC)...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract has a ceiling value of $42,979.58 and an ultimate completion date of April 15, 2025. The contract provides for the delivery of a range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic...
- This is a delivery order award under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued at $999,999,999 through November 2026, provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order has a ceiling value of $13,063.94 and covers the provision of...
- SPE2D021D0003Indefinite Delivery Contract
- SPE2D021D0003-SPE2D024F0104Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Sagent Pharmaceuticals, Inc., a specialty and generic pharmaceutical manufacturer. The $121,974.52 firm fixed price order is for the delivery of various injectable pharmaceutical products, including antibiotics and anesthesia medications, to support military healthcare programs. The order has an April 2025 completion date. This delivery order is issued under a larger $29.6 million indefinite delivery/indefinite quantity (IDIQ) contract that the DLA uses to rapidly procure and distribute critical medicines and medical materiel to U.S. military treatment facilities globally. No set-aside designation was used for this award.
Generated 5/30/24, 10:39 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $122.0k | 2/29/24 |